AAL

Analyst: This Drug Name is a "Top Pick"

Gilead stock ran into resistance at the 200-day moving average last week

Managing Editor
Jul 29, 2019 at 9:13 AM
facebook X logo linkedin


Shares of drugmaker Gilead Sciences, Inc. (NASDAQ:GILD) are up 1.5% in pre-market trading, after the stock received an upgrade to "top pick" from "outperform" out of RBC. The brokerage firm cited new leadership as one reason for its bullish view on GILD stock. Overall, analysts have been extremely optimistic toward the security, with 14 of 19 covering firms sporting a "strong buy" rating, while just five carry a tepid "hold," and the stock's average 12-month price target stands at $80.19, compared to Friday's close of $66.92.

GILD has had a lackluster year on the charts, but despite last week running into resistance at the 200-day moving average, the stock remains 6% higher-year-to-date. We'll see if earnings, due out after the close tomorrow July 30, can spark some more upside for the shares.

However, the security has averaged a modest post-earnings move of just 2.7% during the past two years. Ahead of the event, call buying has remained popular at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), with the 10-day call/put volume ratio at these exchanges standing at 2.45. In the front-month August series, peak call open interest sits at the 70 strike.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.